Current Approaches in Antiviral Drug Discovery Against the Flaviviridae Family
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
3428-3444
Author(s):
Aida Baharuddin, Asfarina Amir Hassan, Gan Chye Sheng, Shah Bakhtiar Nasir, Shatrah Othman, Rohana Yusof, Rozana Othman and Noorsaadah Abdul Rahman
Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2522-2541
Author(s):
L. Lu, J. Shi, Q. Li, X. Peng, L. Dong, Y. Li, P. Dai, Y. Wang, E. Guo, F. Zhou and Z. Liu
Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2346-2356
Author(s):
Joshua K. Ko and Kathy K. Auyeung
Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2950-2977
Author(s):
Gabriella Testa, Fiorella Biasi, Giuseppe Poli and Elena Chiarpotto
PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2843-2848
Author(s):
Chrisostomi Gialeli, Dragana Nikitovic, Dimitris Kletsas, Achilleas D. Theocharis, George N. Tzanakakis and Nikos K. Karamanos
Crosstalk between IGF-1R and other Tumor Promoting Pathways
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2912-2921
Author(s):
Changyu Liu, Zheng Zhang, Hexiao Tang, Zhixiao Jiang, Liangkun You and Yongde Liao
TGF-beta Signaling in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2934-2947
Author(s):
Isabel Fabregat, Joan Fernando, Jessica Mainez and Patricia Sancho
Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2922-2933
Author(s):
Yirui Gui, Mehdi Yeganeh, Yuneivy Cepero-Donates, Sheela Ramanathan, Caroline Saucier and Subburaj Ilangumaran
VEGF Signaling in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2834-2842
Author(s):
Daniela Sia, Clara Alsinet, Pippa Newell and Augusto Villanueva
Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2881-2898
Author(s):
Christine Heinzle, Zeynep Erdem, Jakob Paur, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger and Brigitte Marian